?2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies

Thomsen M., Nordestgaard B.G., Sethi A.A., Tybjærg-Hansen A., Dahl M.

Source: Eur Respir J 2012; 39: 558-566
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Thomsen M., Nordestgaard B.G., Sethi A.A., Tybjærg-Hansen A., Dahl M.. ?2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies. Eur Respir J 2012; 39: 558-566

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017


Lung cancer gene associated with COPD: triple whammy or possible confounding effect?
Source: Eur Respir J 2008; 32: 1158-1164
Year: 2008



CHRNA3 genotype, nicotine dependence, lung function and disease in the general population
Source: Eur Respir J 2012; 40: 1538-1544
Year: 2012



Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015


Asthma in the elderly
Source: Eur Respir Mon; 2009: 43: 56–76
Year: 2009

Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients
Source: Eur Respir J 2008; 32: 372-378
Year: 2008



Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study
Source: Eur Respir J 2012; 40: 28-36
Year: 2012



PPAR-alpha agonist (fenofibrate) therapy in exacerbation control of chronic obstructive pulmonary disease of severe stage
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016


Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue?
Source: Annual Congress 2013 –Asthma and lung development: from genes to environment
Year: 2013

Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study
Source: Eur Respir J 2010; 36: 89-95
Year: 2010



Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016


Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013

Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014


Why is it important to consider (sub)phenotypes of asthma and COPD?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005